Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies

Article   Jul 28, 2016

 
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
 
 
 

RELATED ARTICLES

Microfluidic Method Identifies Rare Antibodies with Therapeutic Potential

Article

A novel microfluidic platform, able to rapidly isolate and identify rare antibodies from a vast repertoire of human B cells, has been developed by scientists. This technology could possess the ability to support and enhance the development of novel vaccines and biopharmaceuticals in the future.

READ MORE

Neuroinformatics and The Blue Brain Project

Article

The Blue Brain Project is an attempt to reverse engineer the rodent brain (and ultimately, the human brain) and recreate it at the cellular level inside a computer simulation.

READ MORE

Developments in Continuous Cell Culture

Article

Continuous cell culture is part of a trend in bioprocessing towards highly productive, streamlined, and interconnected unit operations. While continuous processing has a long history in various industries, regulatory concerns have stalled widespread adoption of continuous bioprocessing. That is beginning to change as the industry acclimates to regulators’ desire for risk- and science-based production decisions.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE